The Department of Veterans Affairs intends to award a sole source contract to Microgenics Corporation for the procurement of FDA-approved CEDIA and DRI Drugs of Abuse reagents, calibrators, and controls specifically for use with Beckman AU480 analyzers at the Minneapolis VA Medical Center. This contract is critical as the Minneapolis VA's Toxicology Laboratory serves as the exclusive national provider for Federal Workplace Urine Drugs of Abuse Testing among VA Hospitals, necessitating compliance with HHS SAMHSA certification through the use of specific FDA-approved products. Interested vendors are invited to submit capability statements by September 18, 2024, to demonstrate their ability to meet the requirements, with all submissions directed to Contract Specialist Alisha Milander at Alisha.Milander@va.gov. The contract is set to commence on October 1, 2024, and will include multiple option years to support ongoing operational needs.